SCHEMBL2516100

SCHEMBL2516100

Cc1ccc(S(=O)(=O)O)c(-c2ccccc2)c1I

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MYC P01106 1/20 0.39
TSHR P16473 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
RCE1 Q9Y256 1/20 0.36
CASP1 P29466 1/20 0.35
LMNA P02545 2/20 0.34
MPL P40238 1/20 0.34
MAPT P10636 1/20 0.34
HTT P42858 1/20 0.34
ALDH1A1 P00352 2/20 0.34
KDM4E B2RXH2 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
MAOB P27338 1/20 0.34
TP53 P04637 1/20 0.34
SUMO2 P61956 1/20 0.33
SUMO1 P63165 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
SENP3 Q9H4L4 1/20 0.33
SENP2 Q9HC62 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22444090 0.87 MYC (0.40) MYCTSHRSMN1; SMN2CASP1LMNA
Iodide SCHEMBL28419660 0.86 MYC (0.39) MYCTSHRSMN1; SMN2RCE1CASP1
SCHEMBL28736762 0.86 MYC (0.39) MYCTSHRSMN1; SMN2RCE1CASP1
SCHEMBL8523878 0.84 ELANE (0.45) MYCTSHRSMN1; SMN2RCE1LMNA
SCHEMBL5597379 0.83 MYC (0.37) MYCTSHRSMN1; SMN2RCE1CASP1
SCHEMBL28348395 0.82 PRKAB2 (0.40) SMN1; SMN2LMNAALDH1A1MEN1KMT2A
SCHEMBL4838484 0.78 ALDH1A1 (0.49) TSHRSMN1; SMN2MAPTALDH1A1KMT2A
SCHEMBL28166154 0.77 TSHR (0.36) MYCTSHRSMN1; SMN2RCE1CASP1
SCHEMBL20875060 0.77 ATM (0.41) MYCCASP1LMNAKMT2AMAOB
SCHEMBL27534698 0.77 BACE1 (0.44) TSHRSMN1; SMN2LMNAMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2365974-B1 FLUORINATED BENZOTHIAZOLE DERIVATIVES, PREPARATION METHOD THEREOF AND IMAGING AGENT FOR DIAGNOSING ALTZHEIMER'S DISEASE USING THE SAME SNU R&DB FOUNDATION (KR) 2013-12-25 EP claimed
EP-2365974-B1 FLUORINATED BENZOTHIAZOLE DERIVATIVES, PREPARATION METHOD THEREOF AND IMAGING AGENT FOR DIAGNOSING ALTZHEIMER'S DISEASE USING THE SAME SNU R&DB FOUNDATION (KR) 2013-12-25 EP disclosed
US-20110250136-A1 FLUORINATED BENZOTHIAZOLE DERIVATIVES, PREPARATION METHOD THEREOF AND IMAGING AGENT FOR DIAGNOSING ALTZHEIMER'S DISEASE USING THE SAME SNU R&DB FOUNDATION (KR) 2011-10-13 US disclosed
EP-2365974-A1 FLUORINATED BENZOTHIAZOLE DERIVATIVES, PREPARATION METHOD THEREOF AND IMAGING AGENT FOR DIAGNOSING ALTZHEIMER'S DISEASE USING THE SAME SNU R&DB Foundation (KR) 2011-09-21 EP disclosed
WO-2010053218-A1 FLUORINATED BENZOTHIAZOLE DERIVATIVES, PREPARATION METHOD THEREOF AND IMAGING AGENT FOR DIAGNOSING ALTZHEIMER'S DISEASE USING THE SAME SNU R&DB FOUNDATION (KR) 2010-05-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110250136-A1 FLUORINATED BENZOTHIAZOLE DERIVATIVES, PREPARATION METHOD THEREOF AND IMAGING AGENT FOR DIAGNOSING ALTZHEIMER'S DISEASE USING THE SAME APBA1, APP, PSEN1 MYC 4697/4885TSHR 4126/4885SMN1; SMN2 1366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.